arrow
N

Nikolaos G. Papadopoulos

National and Kapodistrian University of Athens
H指数:117
被引数:7.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A SynAir-G Position Statement for the Improvement of Indoor Air Quality for Children

SynAir-G 关于改善儿童室内空气质量的立场声明

2026-09-010
OAAI
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Global Variation in Timing of Allergenic Food Introduction for Food Allergy Prevention: An International Survey of Healthcare Professionals

全球变应原食物引入时间在食物过敏预防中的差异:一项针对医疗专业人员的国际调查

2026-07-020
OAAI
Distinction between allergic rhinitis alone and allergic rhinitis plus asthma in MASK-air ® real-world studies; a ARIA-WAO task force review

MASK-air ®真实世界研究中单纯过敏性鼻炎与过敏性鼻炎合并哮喘的区分;一项ARIA-WAO工作组综述

2026-07-010
OAAI
EAACI Guidelines on Environmental Science for Allergy and Asthma—Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy

欧洲过敏与临床免疫学会关于环境科学对过敏和哮喘的指南——基于证据的建议:为预防及公共卫生行动以减轻花粉暴露对呼吸道过敏的影响

2026-06-260
PRE
Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts

全球过敏性鼻炎治疗的可及性与成本:ARIA专家调查

2026-04-180
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Frequency and Severity of Allergic Reactions to Non-Mandatory Labelled Allergenic Foods—Data From Two Large European Cohorts

对非强制标示过敏原食物过敏反应的频率和严重程度——来自两项大型欧洲队列研究的数据

2026-03-230
OAAI
ZENIA: Development of an AI-driven nutrition app to support immune health: An EAACI task force report

ZENIA:开发一款AI驱动的营养应用程序以支持免疫健康:EAACI工作组报告

2026-02-270
OAAI
The EUFOREA pocket guide on paediatric asthma: A step forward in patient care

欧盟儿童哮喘口袋指南:患者护理的进步

2026-01-011
PRE
Exposures in Indoor Air Affecting Health

影响健康的室内空气暴露

2025-12-040
OAAI
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data

基于移动健康数据,采用目标试验模拟方法评估过敏性鼻炎药物的有效性

2025-11-010
OAAI
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report

过敏性鼻炎治疗对患者满意度的影响比较:一项MASK-air和EAACI方法学委员会报告

2025-09-260
OAAI
A World Allergy Organization (WAO) manifesto for the worldwide approval of biologic therapies for food allergy

世界过敏组织(WAO)关于全球批准生物疗法治疗食物过敏的宣言

2025-09-200
PREAI